Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey
LG Hemkens, DG Contopoulos-Ioannidis… - bmj, 2016 - bmj.com
Objective To assess differences in estimated treatment effects for mortality between
observational studies with routinely collected health data (RCD; that are published before …
observational studies with routinely collected health data (RCD; that are published before …
Using nationwide'big data'from linked electronic health records to help improve outcomes in cardiovascular diseases: 33 studies using methods from epidemiology …
H Hemingway, GS Feder, NK Fitzpatrick… - … grants for applied …, 2017 - discovery.ucl.ac.uk
BACKGROUND: Electronic health records (EHRs), when linked across primary and
secondary care and curated for research use, have the potential to improve our …
secondary care and curated for research use, have the potential to improve our …
Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction—a hospital registry-primary …
R Boggon, TP van Staa, A Timmis… - European heart …, 2011 - academic.oup.com
Aims Adherence to evidence-based treatments and its consequences after acute myocardial
infarction (MI) are poorly defined. We examined the extent to which clopidogrel treatment …
infarction (MI) are poorly defined. We examined the extent to which clopidogrel treatment …
Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention
The no reflow phenomenon is reported to occur in> 2% of all percutaneous coronary
interventions (PCIs) and portends a poor prognosis. We analyzed data from 5,286 …
interventions (PCIs) and portends a poor prognosis. We analyzed data from 5,286 …
Progress towards a national cardiac procedure database—development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne …
W Chan, DJ Clark, AE Ajani, CH Yap… - Heart, Lung and …, 2011 - Elsevier
Since the call for a National Cardiac Procedures Database in 2001, much work has been
accomplished in both cardiac surgery and interventional cardiology in an attempt to …
accomplished in both cardiac surgery and interventional cardiology in an attempt to …
Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents
I Ben-Dor, R Torguson, M Scheinowitz, Y Li… - American heart …, 2010 - Elsevier
BACKGROUND: Nuisance bleeding (NB) after dual antiplatelet therapy (DAPT) is not well
characterized despite its potential to impact patient compliance. We therefore aimed to …
characterized despite its potential to impact patient compliance. We therefore aimed to …
Optimal duration of dual antiplatelet therapy after implantation of drug-eluting stents: shorter or longer?
M Chang, DW Park - Cardiology and Therapy, 2014 - Springer
Use of dual antiplatelet therapy (DAPT; the combination of aspirin and an inhibitor of platelet
P2Y 12) is the key pharmacological component in the management of acute coronary …
P2Y 12) is the key pharmacological component in the management of acute coronary …
Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention
There are few data on the incidence and clinical outcomes of patients with atrial fibrillation
(AF) treated in the era of percutaneous coronary intervention (PCI). We analyzed 30-day …
(AF) treated in the era of percutaneous coronary intervention (PCI). We analyzed 30-day …
Factors associated with clopidogrel use, adherence, and persistence in patients with acute coronary syndromes undergoing percutaneous coronary intervention
B Zhu, Z Zhao, P McCollam, J Anderson… - … medical research and …, 2011 - Taylor & Francis
Objective: Recent guidelines recommend use of aspirin and either clopidogrel or prasugrel
for at least 12 months following use of drug-eluting or bare metal stents in patients with acute …
for at least 12 months following use of drug-eluting or bare metal stents in patients with acute …
Effectiveness of two-year clopidogrel+ aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year …
G Tanzilli, C Greco, F Pelliccia, V Pasceri… - The American journal of …, 2009 - Elsevier
It remains unclear whether dual antiplatelet therapy> 12 months might carry a better
prognosis after percutaneous coronary intervention (PCI) with drug-eluting stents (DESs). To …
prognosis after percutaneous coronary intervention (PCI) with drug-eluting stents (DESs). To …